AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENDRA Life Sciences Inc. Director's Dealing 2018

Dec 17, 2018

Director's Dealing

Opens in your device viewer

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2018-12-13

Reporting Person: Thornton Michael Milos (Chief Technology Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-13	Stock Options	$2.25	A	125000	Acquired	2026-12-13	Common Stock (125000)	Direct

F1: These Stock Options become exercisable in three equal annual installments beginning on December 13, 2019.